The patient will meet with the provider after the 3rd, 8th, and 14th treatment. The provider will decide if maintenance (biweekly treatment) is medically necessary, going forward.
SPRAVATO© (Esketamine) is an FDA-approved nasal spray prescription medication for adults with treatment-resistant depression to be used along with an oral antidepressant for adults with major depressive disorder (MDD), patients who have had an insufficient response to 2 or more oral ADs, and adults with MDD, along with acute suicidal ideation or behavior (MDSI).
As a groundbreaking breakthrough in psychiatric care, Spravato employs a novel approach that targets key molecules, receptors, and mechanisms in the brain, setting it apart from conventional treatment methods. Embark on a transformative journey towards lasting relief from severe depression through our comprehensive Spravato treatment in Linwood at Shore Clinical TMS Therapy and Wellness Center.
Patients in Linwood often report many benefits of Spravato treatment.
If you find yourself within the challenging realm of severe depression resistant to traditional antidepressants, Spravato (Esketamine) emerges as a novel and promising option. Our experienced team is dedicated to providing personalized care, guiding you through a tailored treatment plan that incorporates the transformative potential of Spravato. Your path to renewed well-being begins with the innovative and scientifically-backed Spravato treatment at Shore Clinical TMS & Wellness Center, where we are committed to fostering lasting relief and empowering you on your journey to mental health.
SPRAVATO nasal spray is self-administered under a healthcare provider’s supervision in a certified treatment center that’s registered in the SPRAVATO© Risk Evaluation and Mitigation Strategy (REMS) Program.
Our treatment center in Linwood will provide a relaxing, meditative environment to instill mindfulness, mental wellness, and positivity throughout the Spravato treatment.
Treatment Frequency:
The patient will meet with the provider after the 3rd, 8th, and 14th treatment. The provider will decide if maintenance (biweekly treatment) is medically necessary, going forward.
If you’re eligible and commercially insured in Linwood, the Spravato With Me Savings Program may help you pay as little as $10 per treatment. Of course, there are quantity limits and savings limits each year. These savings may apply to your co-pay, co-insurance, or deductible. The program doesn’t cover the cost of treatment observation, only the medication itself.
You can participate without sharing your income information. Check program requirements at spravato.com/SavingsRequirements.
If you’ve taken two or more antidepressants with the prescribed dose and duration, and still struggle with depressive symptoms, talk with your healthcare provider to see if SPRAVATO© is right for you. Patients must also score adequately on a standardized depression scale and should currently be taking an antidepressant.
The most commonly-used oral antidepressants target neurotransmitters such as serotonin, dopamine, or norepinephrine. SPRAVATO targets the N-methyl-D-aspartate (NMDA) receptor and is believed to work differently from typical oral antidepressants. But the exact method is unknown.
A full course of Spravato nasal spray treatment ordinarily requires 6-8 weeks of treatment (once or twice a week), with less frequent maintenance treatment in the following months. For the first 4 weeks you come in twice per week, each time for a two-and-a-half-hour visit.
In the second month your visits are once per week. After that, treatments for long-term maintenance with Spravato (esketamine) might be once per week or twice per month, depending on your clinical course.
Common side effects include transient sedation, a possible rise in your blood pressure, abuse and misuse, increased suicidal ideation or behavior, increased blood pressure, problems with thinking clearly, bladder problems, and feelings of dissociation (such as feeling strange, disconnected, or change in sense of time).
Other side effects include:
These side effects may typically be present for the first 40 minutes after taking the nasal spray of ketamine. If such side effects occur, they typically disappear the same day.
We accept most insurances and will work with your insurance company to cover this service. Some or all of our charges for this treatment may be covered by your insurance.
Please call your insurance company and ask if treatment with Spravato (esketamine) is covered.
The manufacturer of Spravato (Janssen) also provides assistance for patients in determining insurance coverage and may be able to provide some financial support for your treatment as well.
Please call the Janssen CarePath Program at 844-777-2828.
This is prohibited by the FDA, as ketamine has the potential to be abused, and can therefore lead to addiction. Therefore, its administration must solely be at the doctor’s office.
